Arati Chand in Los Angeles, California

Home California Los Angeles

Arati Chand has Hematology/oncology as her primary medical specialty. Their primary office is: 1701 E Cesar Chavez Ave in Los Angeles, California.

They're a part of the: The Oncology Institute Ca, A Professional Corporation medical group which has around 65 members. You can call their office at 323-284-4077 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 2005 (around 19 years of experience). They are listed as doing telehealth appointments.

Arati R Chand Office Phone and Directions

Arati Chand
The Oncology Institute Ca, A Professional Corporation
1701 E Cesar Chavez Ave
Los Angeles, California 90033
323-284-4077

Patient Ratings
Please rate your experience with Arati Chand below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 323-284-4077

Enter a starting address:

Healthcare Info for Arati Chand

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2005
The Primary Medical Specialty for Arati Chand is listed as: Hematology/oncology
Approximate Years of Experience: 19
PAC (PECOS ID)#: 2961641006
NPI #: 1942434212
NPI Created On: 05/14/2009
NPI Last Updated Listed as: 11/19/2018
Primary Taxonomy Code: 390200000X
License Number:
BP10034216
Listed Gender: Female

Procedures, Services, Charges

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Infusion of chemotherapy into a vein up to 1 hour
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 30 minutes per day
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Physician telephone patient service, 5-10 minutes of medical discussion
Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
Infusion, normal saline solution, sterile (500 ml = 1 unit)

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788847459

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788847457

Being Disputed:: No

Product Related: No

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 799849647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: ONCOLOGY

Name of Drug #1: FOUNDATIONONE

Drug or Biological: Device

Product Category #2: ONCOLOGY

Name Of Drug #2:: FOUNDATIONONE CDX

Drug or Biological #3:: Device

Product Category #3: ONCOLOGY

Name of Drug: FOUNDATIONONE HEME

Drug or Biological: Device

Product Category #4: ONCOLOGY

Name of Drug #4: FOUNDATIONONE LIQUID CDX

Drug or Biological #4:: Device

Product Category #5: ONCOLOGY

Name of Drug #5: FOUNDATIONFOCUS

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008735

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008737

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $28

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008741

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008743

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $65

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008749

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781008745

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Hematology/oncology Professionals in Los Angeles

1.
Julie Huynh

8635 W 3rd St
Los-angeles, CA
Cedars-sinai Medical Care Foundation

2.
Vina Nguyen

6041 Cadillac Ave
Los-angeles, CA
Southern California Permanente Medical Group

3.
Cecilia Fu

4650 W Sunset Blvd
Los-angeles, CA
Childrens Hospital Los Angeles Medical Group Inc

4.
Guy Young MD

4650 W Sunset Blvd
Los-angeles, CA
Childrens Hospital Los Angeles Medical Group Inc

5.
George Yaghmour

1520 San Pablo St 1st Floor N
Los-angeles, CA
Usc Care Medical Group Inc

6.
George Yaghmour

1520 San Pablo St
Los-angeles, CA
Usc Care Medical Group Inc

Providers in The Oncology Institute Ca, A Professional Corporation

1.Sami Ali

1513 S Grand Ave
Los Angeles Ca 90015-3465
The Oncology Institute Ca, A Professional Corporation
Hematology/oncology

2.Lata Aluri Md

6565 E Carondelet Dr
Tucson Az 85710-3529
The Oncology Institute Ca, A Professional Corporation
Hematology/oncology

3.Lata Aluri Md

1707 W Saint Marys Rd
Tucson Az 85745-2629
The Oncology Institute Ca, A Professional Corporation
Hematology/oncology

4.Jeffrey Andrey

31515 Rancho Pueblo Rd
Temecula Ca 92592-4837
The Oncology Institute Ca, A Professional Corporation
Hematology

5.Nenad Antic Md

1513 S Grand Ave
Los Angeles Ca 90015-3465
The Oncology Institute Ca, A Professional Corporation
Hematology/oncology

6.Nenad Antic Md

101 E Beverly Blvd
Montebello Ca 90640-4315
The Oncology Institute Ca, A Professional Corporation
Hematology/oncology

View all 65 members of The Oncology Institute Ca, A Professional Corporation medical group